You may find more results for this query on our sister sites: GenomeWeb and Precision Oncology News.
Technology partners on the study include BioMérieux and SkylineDx, as well as Imperial College London's biomedical electronics unit.
The funding, part of a larger initiative by Genome Canada, will support two studies in British Columbia that will evaluate genomics in healthcare.
The researchers envisage deploying a point-of-care assay based on a fluorescent nanophotonics platform.
The funding comes from the Bill and Melinda Gates Foundation, which previously provided the company with $500,000 for the test's initial development.
The funds will support the companies' efforts to develop tests for predicting NSCLC patients' response to immunotherapy.
The grants were awarded through the organization's Diagnostic Accelerator, a partnership between the charity and various philanthropic partners.
The grant will support the development of a high-throughput method to extract and test dried blood samples collected by patients at home.
The grant was awarded through the Alzheimer's Drug Discovery Foundation's Diagnostic Accelerator, a partnership between the charity and philanthropic partners.
The Finnish company also announced that it has received CE-IVD marking for its Aiforia Clinical pathology image analysis platform.
The educational grant will support UpToDate's development of technology to help medical professionals advise their patients on health implications of genetic tests.